Karolinska Development AB | |
Stock Exchange | OTC Publication Venue |
EPS |
SEK0.49 |
Market Cap |
SEK244.51 M |
Shares Outstanding |
62.92 M |
Public Float |
50.03 M |
Address |
Tomtebodavägen 23A Solna AB 171 65 Sweden |
Employees | - |
Website | http://www.karolinskadevelopment.com |
Updated | 07/08/2019 |
Karolinska Development AB engages in the investment in pharmaceutical business. It invests in companies that develop medical innovations, specialty care products and orphan drugs for patients suffering from life-threatening and serious debilitating conditions. Its funds are obtained from independent investors and shareholders by issuing and selling shares and interest-bearing instruments. |